Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 169


Predicting stroke in patients without atrial fibrillation.

Steensig K, Olesen KKW, Thim T, Nielsen JC, Madsen M, Jensen SE, Jensen LO, Kristensen SD, Lip GYH, Maeng M.

Eur J Clin Invest. 2019 Mar 18:e13103. doi: 10.1111/eci.13103. [Epub ahead of print]


Fractional Flow Reserve Versus Angiographically-Guided Coronary Artery Bypass Grafting.

Thuesen AL, Riber LP, Veien KT, Christiansen EH, Jensen SE, Modrau I, Andreasen JJ, Junker A, Mortensen PE, Jensen LO.

J Am Coll Cardiol. 2018 Dec 4;72(22):2732-2743. doi: 10.1016/j.jacc.2018.09.043.


Should the Presence or Extent of Coronary Artery Disease be Quantified in the CHA2DS2-VASc Score in Atrial Fibrillation? A Report from the Western Denmark Heart Registry.

Steensig K, Olesen KKW, Thim T, Nielsen JC, Jensen SE, Jensen LO, Kristensen SD, Bøtker HE, Lip GYH, Maeng M.

Thromb Haemost. 2018 Dec;118(12):2162-2170. doi: 10.1055/s-0038-1675401. Epub 2018 Nov 12.


Three-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and a durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction (TROFI II trial).

Katagiri Y, Onuma Y, Asano T, Iñiguez A, Jensen LO, Cequier À, Hofma SH, Christiansen EH, Suttorp M, Brugaletta S, Räber L, Sabaté M, Windecker S, Serruys PW.

EuroIntervention. 2018 Dec 7;14(11):e1224-e1226. doi: 10.4244/EIJ-D-18-00839. No abstract available.


Comparison of Frequency of Ischemic Stroke in Patients With Versus Without Coronary Heart Disease and Without Atrial Fibrillation.

Olesen KKW, Steensig K, Madsen M, Thim T, Jensen LO, Raungaard B, Eikelboom J, Kristensen SD, Bøtker HE, Maeng M.

Am J Cardiol. 2019 Jan 1;123(1):153-158. doi: 10.1016/j.amjcard.2018.09.011. Epub 2018 Sep 26.


Smoking is the dominating modifiable risk factor in younger patients with STEMI.

Gleerup HB, Dahm CC, Thim T, Jensen SE, Jensen LO, Kristensen SD, Bøtker HE, Maeng M.

Eur Heart J Acute Cardiovasc Care. 2018 Nov 2:2048872618810414. doi: 10.1177/2048872618810414. [Epub ahead of print]


Lactate is a Prognostic Factor in Patients Admitted With Suspected ST-Elevation Myocardial Infarction.

Frydland M, Møller JE, Wiberg S, Lindholm MG, Hansen R, Henriques JPS, Møller-Helgestad OK, Bang LE, Frikke-Schmidt R, Goetze JP, Udesen NLJ, Thomsen JH, Ouweneel DM, Obling L, Ravn HB, Holmvang L, Jensen LO, Kjaergaard J, Hassager C.

Shock. 2019 Mar;51(3):321-327. doi: 10.1097/SHK.0000000000001191.


Coronary stent implantation and adverse cardiac events after surgery.

Thim T, Egholm G, Olesen KKW, Madsen M, Jensen SE, Jensen LO, Bøtker HE, Kristensen SD, Maeng M.

Eur J Clin Invest. 2018 Dec;48(12):e13030. doi: 10.1111/eci.13030. Epub 2018 Oct 8.


Impact of diabetes on clinical outcomes after revascularization with sirolimus-eluting and biolimus-eluting stents with biodegradable polymer from the SORT OUT VII trial.

Ellert J, Christiansen EH, Maeng M, Raungaard B, Jensen SE, Kristensen SD, Veien KT, Junker AB, Jakobsen L, Aarøe J, Terkelsen CJ, Kahlert J, Villadsen AB, Bøtker HE, Jensen LO.

Catheter Cardiovasc Interv. 2019 Mar 1;93(4):567-573. doi: 10.1002/ccd.27891. Epub 2018 Sep 23.


CAD Is an Independent Risk Factor for Stroke Among Patients With Atrial Fibrillation.

Steensig K, Olesen KKW, Thim T, Nielsen JC, Jensen SE, Jensen LO, Kristensen SD, Bøtker HE, Lip GYH, Maeng M.

J Am Coll Cardiol. 2018 Nov 13;72(20):2540-2542. doi: 10.1016/j.jacc.2018.08.1046. Epub 2018 Aug 26. No abstract available.


Proteomic Discovery and Validation of the Confounding Effect of Heparin Administration on the Analysis of Candidate Cardiovascular Biomarkers.

Beck HC, Jensen LO, Gils C, Ilondo AMM, Frydland M, Hassager C, Møller-Helgestad OK, Møller JE, Rasmussen LM.

Clin Chem. 2018 Oct;64(10):1474-1484. doi: 10.1373/clinchem.2017.282665. Epub 2018 Aug 16.


Comparison between patients included in randomized controlled trials of ischemic heart disease and real-world data. A nationwide study.

Laursen PN, Holmvang L, Lønborg J, Køber L, Høfsten DE, Helqvist S, Clemmensen P, Kelbæk H, Jørgensen E, Lassen JF, Pedersen F, Høi-Hansen T, Therkelsen CJ, Tilsted HH, Jensen LO, Nepper-Christensen L, Sadjadieh G, Engstrøm T.

Am Heart J. 2018 Oct;204:128-138. doi: 10.1016/j.ahj.2018.05.018. Epub 2018 Aug 10.


15-O-water myocardial flow reserve PET and CT angiography by full hybrid PET/CT as a potential alternative to invasive angiography.

Thomassen A, Braad PE, Pedersen KT, Petersen H, Johansen A, Diederichsen ACP, Mickley H, Jensen LO, Knuuti J, Gerke O, Høilund-Carlsen PF.

Int J Cardiovasc Imaging. 2018 Dec;34(12):2011-2022. doi: 10.1007/s10554-018-1420-3. Epub 2018 Jul 31.


Validation of the European Society of Cardiology and European Society of Anaesthesiology non-cardiac surgery risk score in patients treated with coronary drug-eluting stent implantation.

Norderud K, Egholm G, Thim T, Olesen KKW, Madsen M, Jensen LO, Bøtker HE, Kristensen SD, Maeng M.

Eur Heart J Qual Care Clin Outcomes. 2019 Jan 1;5(1):22-27. doi: 10.1093/ehjqcco/qcy032.


Prospective Comparison of FFR Derived From Coronary CT Angiography With SPECT Perfusion Imaging in Stable Coronary Artery Disease: The ReASSESS Study.

Sand NPR, Veien KT, Nielsen SS, Nørgaard BL, Larsen P, Johansen A, Hess S, Deibjerg L, Husain M, Junker A, Thomsen KK, Rohold A, Jensen LO.

JACC Cardiovasc Imaging. 2018 Nov;11(11):1640-1650. doi: 10.1016/j.jcmg.2018.05.004. Epub 2018 Jun 13.


Randomized clinical comparison of the dual-therapy CD34 antibody-covered sirolimus-eluting Combo stent with the sirolimus-eluting Orsiro stent in patients treated with percutaneous coronary intervention: Rationale and study design of the Scandinavian Organization for Randomized Trials with Clinical Outcome (SORT OUT) X trial.

Jakobsen L, Christiansen EH, Maeng M, Kristensen SD, Bøtker HE, Terkelsen CJ, Madsen M, Raungaard B, Jensen SE, Christensen MK, Hansen HS, Jensen LO.

Am Heart J. 2018 Aug;202:49-53. doi: 10.1016/j.ahj.2018.04.019. Epub 2018 May 5.


The Western Denmark Heart Registry: Its Influence on Cardiovascular Patient Care.

Schmidt M, Maeng M, Madsen M, Sørensen HT, Jensen LO, Jakobsen CJ.

J Am Coll Cardiol. 2018 Mar 20;71(11):1259-1272. doi: 10.1016/j.jacc.2017.10.110. Review. Erratum in: J Am Coll Cardiol. 2018 Jun 26;71(25):2989-2990.


How should I treat a bioresorbable vascular scaffold edge restenosis and intra-scaffold dissection?

Fallesen CO, Antonsen L, Thayssen P, Jensen LO, Lee PH, Lee SW, Park SJ, Moscarella E, Spitaleri G, Brugaletta S.

EuroIntervention. 2018 Feb 20;13(14):1730-1734. doi: 10.4244/EIJ-D-17-00309. No abstract available.


Plasma Concentration of Biomarkers Reflecting Endothelial Cell- and Glycocalyx Damage are Increased in Patients With Suspected ST-Elevation Myocardial Infarction Complicated by Cardiogenic Shock.

Frydland M, Ostrowski SR, Møller JE, Hadziselimovic E, Holmvang L, Ravn HB, Jensen LO, Pettersson AS, Kjaergaard J, Lindholm MG, Johansson PI, Hassager C.

Shock. 2018 Nov;50(5):538-544. doi: 10.1097/SHK.0000000000001123.


One-year rehospitalisation after percutaneous coronary intervention: a retrospective analysis.

Hansen KN, Bendix K, Antonsen L, Veien KT, Mæng M, Junker A, Christiansen EH, Kahlert J, Terkelsen CJ, Christensen LB, Fallesen CO, Boetker HE, Jensen LO.

EuroIntervention. 2018 Oct 20;14(8):926-934. doi: 10.4244/EIJ-D-17-00800.


Association of common genetic variants related to atrial fibrillation and the risk of ventricular fibrillation in the setting of first ST-elevation myocardial infarction.

Jabbari R, Jabbari J, Glinge C, Risgaard B, Sattler S, Winkel BG, Terkelsen CJ, Tilsted HH, Jensen LO, Hougaard M, Haunsø S, Engstrøm T, Albert CM, Tfelt-Hansen J.

BMC Med Genet. 2017 Nov 21;18(1):138. doi: 10.1186/s12881-017-0497-1.


Single-centre experience with the Impella CP, 5.0 and RP in 109 consecutive patients with profound cardiogenic shock.

Jensen PB, Kann SH, Veien KT, Møller-Helgestad OK, Dahl JS, Rud CS, Jensen MK, Jensen LO, Schmidt H, Møller JE.

Eur Heart J Acute Cardiovasc Care. 2018 Feb;7(1):53-61. doi: 10.1177/2048872617743194. Epub 2017 Nov 17.


Long-term prognosis of patients with non-ST-segment elevation myocardial infarction according to coronary arteries atherosclerosis extent on coronary angiography: a historical cohort study.

Alzuhairi KS, Søgaard P, Ravkilde J, Azimi A, Mæng M, Jensen LO, Torp-Pedersen C.

BMC Cardiovasc Disord. 2017 Nov 16;17(1):279. doi: 10.1186/s12872-017-0710-3.


Association between QRS duration on prehospital ECG and mortality in patients with suspected STEMI.

Hansen R, Frydland M, Møller-Helgestad OK, Lindholm MG, Jensen LO, Holmvang L, Ravn HB, Kjærgaard J, Hassager C, Møller JE.

Int J Cardiol. 2017 Dec 15;249:55-60. doi: 10.1016/j.ijcard.2017.07.049.


Intravascular ultrasound assessment of minimum lumen area and intimal hyperplasia in in-stent restenosis after drug-eluting or bare-metal stent implantation. The Nordic Intravascular Ultrasound Study (NIVUS).

Jensen LO, Vikman S, Antonsen L, Kosonen P, Niemelä M, Christiansen EH, Kervinen K, Erglis A, Harnek J, Kumsars I, Thuesen L, Niemelä K.

Cardiovasc Revasc Med. 2017 Dec;18(8):577-582. doi: 10.1016/j.carrev.2017.05.010. Epub 2017 May 12.


Percutaneous biventricular cardiac assist device in cardiogenic shock and refractory cardiac arrest.

Ellert J, Jensen MJ, Jensen LO, Møller JE.

EuroIntervention. 2018 Apr 6;13(18):e2114-e2115. doi: 10.4244/EIJ-D-17-00637. No abstract available.


Stent implantation and vascular healing of a spontaneous coronary artery dissection assessed by optical coherence tomography in a patient with acute coronary syndrome.

Hansen KN, Antonsen L, Jensen LO.

Cardiovasc Revasc Med. 2018 Apr - May;19(3 Pt B):376-379. doi: 10.1016/j.carrev.2017.08.017. Epub 2017 Sep 5.


Quality assurance of the Western Denmark Heart Registry, a population-based healthcare register.

Rasmussen LA, Bøtker HE, Jensen LO, Ravkilde J, Riber L, Nielsen PH, Andreasen JJ, Jakobsen CJ.

Dan Med J. 2017 Oct;64(10). pii: A5414.


Data on association between QRS duration on prehospital ECG and mortality in patients with confirmed STEMI.

Hansen R, Frydland M, Møller-Helgestad OK, Lindholm MG, Jensen LO, Holmvang L, Ravn HB, Kjærgaard J, Hassager C, Møller JE.

Data Brief. 2017 Sep 5;15:12-17. doi: 10.1016/j.dib.2017.08.051. eCollection 2017 Dec.


The SABRE Trial (Sirolimus Angioplasty Balloon for Coronary In-Stent Restenosis): Angiographic Results and 1-Year Clinical Outcomes.

Verheye S, Vrolix M, Kumsars I, Erglis A, Sondore D, Agostoni P, Cornelis K, Janssens L, Maeng M, Slagboom T, Amoroso G, Jensen LO, Granada JF, Stella P.

JACC Cardiovasc Interv. 2017 Oct 23;10(20):2029-2037. doi: 10.1016/j.jcin.2017.06.021. Epub 2017 Sep 27.


Effect of Post-Dilatation Following Primary PCI With Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stent Implantation: An Angiographic and Optical Coherence Tomography TROFI II Substudy.

Yamaji K, Brugaletta S, Sabaté M, Iñiguez A, Jensen LO, Cequier A, Hofma SH, Christiansen EH, Suttorp M, van Es GA, Sotomi Y, Onuma Y, Serruys PW, Windecker S, Räber L.

JACC Cardiovasc Interv. 2017 Sep 25;10(18):1867-1877. doi: 10.1016/j.jcin.2017.07.035.


Two-year outcome after biodegradable polymer sirolimus- and biolimus-eluting coronary stents (from the randomised SORT OUT VII trial).

Jensen LO, Maeng M, Raungaard B, Hansen KN, Kahlert J, Jensen SE, Hansen HS, Lassen JF, Bøtker HE, Christiansen EH.

EuroIntervention. 2018 Jan 20;13(13):1587-1590. doi: 10.4244/EIJ-D-17-00731. No abstract available.


Final five-year outcomes after implantation of biodegradable polymer-coated biolimus-eluting stents versus durable polymer-coated sirolimus-eluting stents.

Jakobsen L, Christiansen EH, Maeng M, Hansen KN, Kristensen SD, Bøtker HE, Terkelsen CJ, Jensen SE, Raungaard B, Madsen M, Lassen JF, Jensen LO.

EuroIntervention. 2017 Dec 20;13(11):1336-1344. doi: 10.4244/EIJ-D-17-00434.


Coronary artery disease and risk of adverse cardiac events and stroke.

Olesen KKW, Madsen M, Lip GYH, Egholm G, Thim T, Jensen LO, Raungaard B, Nielsen JC, Bøtker HE, Sørensen HT, Maeng M.

Eur J Clin Invest. 2017 Nov;47(11):819-828. doi: 10.1111/eci.12804. Epub 2017 Sep 14.


Outcome of revascularisation in stable coronary artery disease without ischaemia: a Danish registry-based follow-up study.

Simonsen JA, Mickley H, Johansen A, Hess S, Thomassen A, Gerke O, Jensen LO, Hallas J, Vach W, Hoilund-Carlsen PF.

BMJ Open. 2017 Aug 11;7(8):e016169. doi: 10.1136/bmjopen-2017-016169.


Uncovered Culprit Plaque Ruptures in Patients With ST-Segment Elevation Myocardial Infarction Assessed by Optical Coherence Tomography and Intravascular Ultrasound With iMap.

Hougaard M, Hansen HS, Thayssen P, Antonsen L, Jensen LO.

JACC Cardiovasc Imaging. 2018 Jun;11(6):859-867. doi: 10.1016/j.jcmg.2017.03.019. Epub 2017 Jul 19.


Severe Mental Illness and Clinical Outcome After Primary Percutaneous Coronary Intervention.

Jakobsen L, Terkelsen CJ, Christiansen EH, Maeng M, Jensen LO, Veien K, Raungaard B, Jensen SE, Mehnert F, Johnsen SP.

Am J Cardiol. 2017 Aug 15;120(4):550-555. doi: 10.1016/j.amjcard.2017.05.021. Epub 2017 May 30.


Design and rationale for the Influenza vaccination After Myocardial Infarction (IAMI) trial. A registry-based randomized clinical trial.

Fröbert O, Götberg M, Angerås O, Jonasson L, Erlinge D, Engstrøm T, Persson J, Jensen SE, Omerovic E, James SK, Lagerqvist B, Nilsson J, Kåregren A, Moer R, Yang C, Agus DB, Erglis A, Jensen LO, Jakobsen L, Christiansen EH, Pernow J.

Am Heart J. 2017 Jul;189:94-102. doi: 10.1016/j.ahj.2017.04.003. Epub 2017 Apr 18.


Patients With Diabetes Without Significant Angiographic Coronary Artery Disease Have the Same Risk of Myocardial Infarction as Patients Without Diabetes in a Real-World Population Receiving Appropriate Prophylactic Treatment.

Olesen KKW, Madsen M, Egholm G, Thim T, Jensen LO, Raungaard B, Bøtker HE, Sørensen HT, Maeng M.

Diabetes Care. 2017 Aug;40(8):1103-1110. doi: 10.2337/dc16-2388. Epub 2017 Jun 8.


Risk factors of late cardiogenic shock and mortality in ST-segment elevation myocardial infarction patients.

Obling L, Frydland M, Hansen R, Møller-Helgestad OK, Lindholm MG, Holmvang L, Ravn HB, Wiberg S, Thomsen JH, Jensen LO, Kjærgaard J, Møller JE, Hassager C.

Eur Heart J Acute Cardiovasc Care. 2018 Feb;7(1):7-15. doi: 10.1177/2048872617706503. Epub 2017 Apr 28.


Distance to invasive heart centre, performance of acute coronary angiography, and angioplasty and associated outcome in out-of-hospital cardiac arrest: a nationwide study.

Tranberg T, Lippert FK, Christensen EF, Stengaard C, Hjort J, Lassen JF, Petersen F, Jensen JS, Bäck C, Jensen LO, Ravkilde J, Bøtker HE, Terkelsen CJ.

Eur Heart J. 2017 Jun 1;38(21):1645-1652. doi: 10.1093/eurheartj/ehx104.


Randomized comparison of sirolimus eluting, and biolimus eluting bioresorbable polymer stents: the SORT-OUT VII optical coherence tomography study.

Andreasen LN, Holm NR, Balleby IR, Krusell LR, Maeng M, Jakobsen L, Veien KT, Hansen KN, Kristensen SD, Hjort J, Kaltoft A, Dijkstra J, Terkelsen CJ, Lassen JF, Madsen M, Bøtker HE, Jensen LO, Christiansen EH.

Eur Heart J Cardiovasc Imaging. 2018 Mar 1;19(3):329-338. doi: 10.1093/ehjci/jex035.


Effect of Ischemic Postconditioning During Primary Percutaneous Coronary Intervention for Patients With ST-Segment Elevation Myocardial Infarction: A Randomized Clinical Trial.

Engstrøm T, Kelbæk H, Helqvist S, Høfsten DE, Kløvgaard L, Clemmensen P, Holmvang L, Jørgensen E, Pedersen F, Saunamaki K, Ravkilde J, Tilsted HH, Villadsen A, Aarøe J, Jensen SE, Raungaard B, Bøtker HE, Terkelsen CJ, Maeng M, Kaltoft A, Krusell LR, Jensen LO, Veien KT, Kofoed KF, Torp-Pedersen C, Kyhl K, Nepper-Christensen L, Treiman M, Vejlstrup N, Ahtarovski K, Lønborg J, Køber L; Third Danish Study of Optimal Acute Treatment of Patients With ST Elevation Myocardial Infarction–Ischemic Postconditioning (DANAMI-3–iPOST) Investigators.

JAMA Cardiol. 2017 May 1;2(5):490-497. doi: 10.1001/jamacardio.2017.0022.


Comparison of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: 3-Year Clinical Outcomes in the Randomized SORT OUT VI Trial.

Raungaard B, Christiansen EH, Bøtker HE, Hansen HS, Ravkilde J, Thuesen L, Aarøe J, Villadsen AB, Terkelsen CJ, Krusell LR, Maeng M, Kristensen SD, Veien KT, Hansen KN, Junker A, Madsen M, Andersen SL, Jensen SE, Jensen LO; SORT OUT VI Investigators.

JACC Cardiovasc Interv. 2017 Feb 13;10(3):255-264. doi: 10.1016/j.jcin.2016.11.007. Epub 2017 Jan 18.


Lipid-core burden response to stent implantation assessed with near-infrared spectroscopy and intravascular ultrasound evaluation in patients with myocardial infarction.

Noori M, Thayssen P, Veien KT, Junker A, Hansen KN, Hansen HS, Jensen LO.

Cardiovasc Revasc Med. 2017 Apr - May;18(3):182-189. doi: 10.1016/j.carrev.2016.12.018. Epub 2016 Dec 27.


A Common Variant in SCN5A and the Risk of Ventricular Fibrillation Caused by First ST-Segment Elevation Myocardial Infarction.

Jabbari R, Glinge C, Jabbari J, Risgaard B, Winkel BG, Terkelsen CJ, Tilsted HH, Jensen LO, Hougaard M, Haunsø S, Engstrøm T, Albert CM, Tfelt-Hansen J.

PLoS One. 2017 Jan 13;12(1):e0170193. doi: 10.1371/journal.pone.0170193. eCollection 2017.


Risk Associated With Surgery Within 12 Months After Coronary Drug-Eluting Stent Implantation.

Egholm G, Kristensen SD, Thim T, Olesen KK, Madsen M, Jensen SE, Jensen LO, Sørensen HT, Bøtker HE, Maeng M.

J Am Coll Cardiol. 2016 Dec 20;68(24):2622-2632. doi: 10.1016/j.jacc.2016.09.967.


Influence of ezetimibe in addition to high-dose atorvastatin therapy on plaque composition in patients with ST-segment elevation myocardial infarction assessed by serial: Intravascular ultrasound with iMap: the OCTIVUS trial.

Hougaard M, Hansen HS, Thayssen P, Antonsen L, Junker A, Veien K, Jensen LO.

Cardiovasc Revasc Med. 2017 Mar;18(2):110-117. doi: 10.1016/j.carrev.2016.11.010. Epub 2016 Nov 28.


Patient delay in patients with ST-elevation myocardial infarction: Time patterns and predictors for a prolonged delay.

Nielsen CG, Laut KG, Jensen LO, Ravkilde J, Terkelsen CJ, Kristensen SD.

Eur Heart J Acute Cardiovasc Care. 2017 Oct;6(7):583-591. doi: 10.1177/2048872616676570. Epub 2016 Nov 30.


Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.

Mäkikallio T, Holm NR, Lindsay M, Spence MS, Erglis A, Menown IB, Trovik T, Eskola M, Romppanen H, Kellerth T, Ravkilde J, Jensen LO, Kalinauskas G, Linder RB, Pentikainen M, Hervold A, Banning A, Zaman A, Cotton J, Eriksen E, Margus S, Sørensen HT, Nielsen PH, Niemelä M, Kervinen K, Lassen JF, Maeng M, Oldroyd K, Berg G, Walsh SJ, Hanratty CG, Kumsars I, Stradins P, Steigen TK, Fröbert O, Graham AN, Endresen PC, Corbascio M, Kajander O, Trivedi U, Hartikainen J, Anttila V, Hildick-Smith D, Thuesen L, Christiansen EH; NOBLE study investigators.

Lancet. 2016 Dec 3;388(10061):2743-2752. doi: 10.1016/S0140-6736(16)32052-9. Epub 2016 Oct 31. Erratum in: Lancet. 2016 Dec 3;388(10061):2742.


Supplemental Content

Loading ...
Support Center